Finess is designed to prevent bladder leaks, improving women's health and overall quality of life.
We are demonstrating that a social media driven strategy can be successfully applied to a sensitive consumer health product category and to CPG in general.
Aliso Viejo, CA (PRWEB) March 14, 2016
Soft Health Technologies LLC has been selected to present at the 28th annual ROTH Conference hosted by Roth Capital Group at the Ritz Carlton, Laguna Niguel of Dana Point.
In 2015, Soft Health began commercialization of Finess, a non-internal, clinically validated medical device for female stress urinary incontinence, cleared by the FDA for over-the-counter sale. Now nationally available, this first-of-its-kind women's health innovation designed to actually prevent leaks rather than just absorb them, has become a top selling product in its category on Amazon.
The ROTH Conference is one of the largest gatherings for small and mid-cap organizations, featuring presentations from hundreds of private and public companies in a variety of sectors. With over 3,000 attendees, the conference will draw institutional investors, private equity investors, VC’s, and company executives from around the country. Over the course of three days, guests will have the opportunity to attend company presentations, small group meetings, and panel discussions.
Soft Health Technologies’ CEO and Founder, Thomas Berryman, was invited to present at the ROTH Conference after his winning presentation given at OCTANe's 10th annual Medical Device Investor Forum in November.
“We are very pleased to have the opportunity to tell the Finess story to the diverse group of investment professionals that make up the Roth Conference community,” stated Mr. Berryman. "We are demonstrating that a social media driven strategy can be successfully applied to a sensitive consumer health product category and to CPG in general. In turn, we are pioneering an exceptionally capital-efficient strategy for medical device commercialization.”
About Finess and Soft Health
Finess is the first and most clinically tested medical device for female bladder leakage cleared by the FDA for non-prescription use. Developed by specialists in stress urinary incontinence (“SUI”) and extensively tested in women with SUI, Finess provides the 1-in-4 women suffering with SUI an alternative to absorbent pads or diapers. Finess is placed over the urethral opening and the specially formulated hydrogel adhesive gently seals it in place until it is removed. Through a sneeze, laugh or lifting something heavy, Finess stops the urine from escaping, so there's no fluid to absorb. Finess challenges the age-old thinking of catching urine in pads and puts science to work, enabling women to reclaim their active lifestyles.
Finess was introduced in 2015. On the Finess website, women can privately learn about incontinence, its causes and how Finess can help prevent bladder leaks. Ordering is discreet and confidential through the Finess online store or at Amazon. For more information, visit: https://havefiness.com
Soft Health Technologies, the maker of Finess, is a privately-held medical technology company in Aliso Viejo, CA.